Piperacillin and Tazobactam for Injection USP 3 — Class I drug recall D-1030-2018
Terminated recall by AuroMedics Pharma LLC, reported 2018-07-18, distributed nationwide. Presence of Particulate Matter: identified as glass and silicone material
| Recall number | D-1030-2018 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | AuroMedics Pharma LLC, East Windsor, NJ, United States |
| Recall initiated | 2018-07-02 |
| Classified | 2018-08-02 |
| Reported by FDA | 2018-07-18 |
| Terminated | 2024-10-01 |
| Distributed | Nationwide (US) |
| Quantity | 73,620 single |
| Reason classes | foreign material, specification failure |
| NDC | 55150-0119, 55150-0119-30, 55150-0120, 55150-0120-30, 55150-0121, 55150-0121-50 |
| Lot numbers | PP0317012-A, PP0317059-A |
| Expiration dates | 2019-02-20, 2019-08-20 |
Product
Piperacillin and Tazobactam for Injection USP 3.375 grams per vial, Single-Dose Vial, Rx Only. Manufactured for: Auromedics Pharma LLC 6 Wheeling Road Dayton NJ 08810, Made in India. NDC 55150-120-30
Reason for recall
Presence of Particulate Matter: identified as glass and silicone material
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1030-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.